Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201612072394N35
IRCT201612072394N35
Completed
Phase 2

Effects of consumption of probiotic on symptom severity , quality of life, plasma ACTH and serum cortisol in patients with generalized anxiety disorder

Vice-chancellor for research, Iran University of Medical Sciences0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGeneralized anxiety disorder.Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is free-floating). The dominant symptoms are variable but include complaints of persistent nervousne

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Generalized anxiety disorder.
Sponsor
Vice-chancellor for research, Iran University of Medical Sciences
Enrollment
50
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice-chancellor for research, Iran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •DSM\-V diagnosed of GAD; Adults between 18 and 65 years old; Willing to participate.
  • •exclusion criteria: Having illness including liver disease and kidney disease, diabetes, immune deficiency, etc; Having psychological illnesses including psychosis, Suicidal ideation, bipolar disorder and major depression; People who are expected to have limited partnerships such as forgetfulness and pregnancy; Taking any medication in the previous 1 month; Taking any medication related to psychiatric diseases including antidepressants, antipsychotics, etc. (maximum of two times per week) and antibiotics in the previous 1 month; Taking any supplement including probiotic supplement, fiber, prebiotics, omega\-3, vitamins and minerals in the previous 1 month; Consumption of fermented foods (except yogurt), such as sour cream, acidophilus milk, kefir and some cheeses such as blue vein cheese or Swiss cheese in the previous 1 month; substance abuse; The compliance less than 80%.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
The effects of probiotic supplementation on symptoms and inflammatory biomarkers in women with rheumatoid arthritisRheumatoid Arthritis.Rheumatoid arthritis, unspecified
IRCT201206234105N9Vice chancellor for Research, Tabriz University of Medical Sciences60
Completed
Phase 2
The effect of probiotic administration on severity of the menopausal symptoms and mental healthSeverity of the Menopausal Symptoms and Mental health.Menopausal and female climacteric statesN95.1
IRCT20180707040370N9Hamedan University of Medical Sciences90
Not yet recruiting
Phase 3
Role of probiotics intake on the disease course of arthritis in children.Health Condition 1: M08- Juvenile arthritis
CTRI/2023/12/060403Indian Rheumatology Association
Recruiting
Phase 3
The effect of probiotic supplement on some inflammatory markers in patients with multiple sclerosisMultiple Sclerosis.Multiple sclerosis
IRCT20181210041918N1Ahvaz University of Medical Sciences50
Completed
Not Applicable
The effect of probiotics on gastrointestinal symptoms during endurance exercise and exercise performance in relation to the composition of the gut microbiota/metabolites.
NL-OMON48006Hogeschool Leiden44